PMA P170002S007

Device
RHA2, RHA3, and RHA4 dermal fillers
Applicant
Teoxane S.A.
PMA number
P170002
Supplement
S007
Product code
LMH
Decision date
2019-12-13
Generic name
Implant, dermal, for aesthetic use
Approval order statement
Change in the receiving procedure for raw material Hyaluronic Acid.

Current openFDA PMA Record#

Device
RHA2, RHA3, and RHA4 dermal fillers
Applicant
Teoxane S.A.
PMA number
P170002
Supplement
S007
Product code
LMH
Generic name
Implant, dermal, for aesthetic use
Decision date
2019-12-13
Decision code
OK30
Date received
2019-11-13
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
Change in the receiving procedure for raw material Hyaluronic Acid.